UC DIS.CERT. 09/24 NDA/ DE000HD063V3 /
31/05/2024 21:46:19 | Chg.+0.070 | Bid21:59:30 | Demandez à21:59:30 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
62.530EUR | +0.11% | 62.530 Bid taille: 300 |
62.650 Ask la taille: 300 |
AURUBIS AG | - - | 27/09/2024 | Call |
GlobeNewswire
02:38
Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pe...
GlobeNewswire
01:00
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-li...
GlobeNewswire
02/06
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
02/06
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
02/06
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page